Preimplantation Genetic Testing for Mutations or Structural Rearrangements

For patients with a known genetic disorder or chromosomal abnormality, preimplantation genetic testing for monogenic disorders (PGT-M) or structural rearrangements (PGT-SR) can help prevent passing these conditions to future children.

Like PGT-A, these tests are performed at the blastocyst stage. A small number of cells are biopsied from the embryo and analyzed for specific genetic mutations or chromosomal rearrangements. This process allows our doctors to identify embryos that do not carry the affected genes, reducing the risk of inherited conditions and ensuring the healthiest possible start for your baby.